Modern possibilities for the diagnosis of adenomyosis

Cover Page


Cite item

Full Text

Abstract

This review article presents modern data on the diagnosis and pathogenesis of adenomyosis, various classifications of the disease being highlighted. The role of genetic and immunological factors in the development of internal endometriosis is discussed. The results of domestic and foreign studies are presented, with the most informative non-invasive markers for the diagnosis of adenomyosis described.

About the authors

Maria A. Shalina

The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Author for correspondence.
Email: amarus@inbox.ru
ORCID iD: 0000-0002-5921-3217
SPIN-code: 6673-2660

MD, PhD, Senior Researcher. The Department of Gynecology and Endocrinology

Russian Federation, Saint Petersburg

Maria I. Yarmolinskaya

The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; North-Western State Medical University named after I.I. Mechnikov

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147
SPIN-code: 3686-3605
Scopus Author ID: 7801562649

MD, PhD, DSci (Medicine), Professor of the Russian Academy of Sciences, Head of the Department of Gynecology and Endocrinology, Head of the Diagnostics and Treatment of Endometriosis Center; Professor. The Department of Obstetrics and Gynecology

Russian Federation, Saint Petersburg

Elena I. Abashova

The Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott

Email: abashova@yandex.ru
ORCID iD: 0000-0003-2399-3108
SPIN-code: 2133-0310

MD, PhD, Senior Researcher. The Department of Gynecology and Endocrinology

Russian Federation, Saint Petersburg

References

  1. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update. 2014;20(3):386-402. https://doi.org/10.1093/humupd/dmt052.
  2. Parazzini F, Mais V, Cipriani S, et al.; GISE. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):103-106. https://doi.org/10.1016/ j.ejogrb.2008.12.010.
  3. Reinhold C, Tafazoli F, Mehio A, et al. Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics. 1999;19(Suppl.):S147-160. https://doi.org/10.1148/radiographics.19.suppl_1.g99oc 13s147.
  4. Sammour A, Pirwany I, Usubutun A, et al. Correlations between extent and spread of adenomyosis and clinical symptoms. Gynecol Obstet Invest. 2002;54(4):213-216. https://doi.org/10.1159/000068385.
  5. Irungu S, Mavrelos D, Worthington J, et al. Discovery of non-invasive biomarkers for the diagnosis of endometriosis. Clin Proteomics. 2019;16:14. https://doi.org/10.1186/s12014-019-9235-3.
  6. Warren LA, Shih A, Renteira SM, et al. Analysis of menstrual effluent: diagnostic potential for endometriosis. Mol Med. 2018;24(1):1. https://doi.org/10.1186/s10020-018-0009-6.
  7. Manousopoulou A, Hamdan M, Fotopoulos M, et al. Integrated eutopic endometrium and non-depleted serum quantitative proteomic analysis identifies candidate serological markers of endometriosis. Proteomics Clin Appl. 2019;13(3):e1800153. https://doi.org/10.1002/prca.201800153.
  8. Vlahos NF, Theodoridis TD, Partsinevelos GA. Myomas and adenomyosis: impact on reproductive outcome. Biomed Res Int. 2017;2017:5926470. https://doi.org/10.1155/2017/5926470.
  9. Коган Е.А., Низяева Н.В., Демура Т.А., и др. Морфологические и иммуногистохимические особенности очагов аденомиоза при сочетании с аденокарциномой эндометрия // Архив патологии. − 2010. − Т. 72. − № 4. − С. 7−12. [Kogan EA, Niziaeva NV, Demura TA, et al. The morphological and immunohiochemical features of foci of adenomyosis: in its concurrence with endometrial adenocarcinoma. Arkh Patol. 2010;72(4):7-12. (In Russ.)]
  10. Mehasseb MK, Bell SC, Brown L, et al. Phenotypic characterisation of the inner and outer myometrium in normal and adenomyotic uteri. Gynecol Obstet Invest. 2011;71(4):217-224. https://doi.org/10.1159/000318205.
  11. Emmanuel I, Ochigbo A, Philip A, Nyam EY. Adenomyosis: a clinico-pathological study. West Afr J Med. 2019;36(1):88-92.
  12. Donnez J, Donnez O, Dolmans MM. Introduction: uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018;109(3):369-370. https://doi.org/10.1016/ j.fertnstert.2018.01.035.
  13. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8. pii: F1000 Faculty Rev-283. https://doi.org/10.1016/10.12688/f1000research.17242.1.
  14. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109(3):380-388.e1. https://doi.org/10.1016/j.fertnstert.2018.01.006.
  15. Andersson JK, Khan Z, Weaver AL, et al. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: a pilot study. Acta Obstet Gynecol Scand. 2019;98(10):1341-1350. https://doi.org/10.1111/aogs.13632.
  16. Harada T, Khine YM, Kaponis A, et al. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv. 2016;71(9):557-568. https://doi.org/10.1097/OGX.0000000 000000346.
  17. Шкляр А.А. Диагностика, хирургическое лечение и реабилитация женщин репродуктивного возраста с узловой формой аденомиоза: Дис. … канд. мед. наук. – М., 2015. – 113 с. [Shklyar AA. Diagnostika, khirurgicheskoye lecheniye i reabilitatsiya zhenshchin reproduktivnogo vozrasta s uzlovoy formoy adenomioza. [dissertation] Moscow; 2015. 113 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01005102626. Ссылка активна на 14.12.2019.
  18. Ярмолинская М.И., Айламазян Э.К. Генитальный эндометриоз. Различные грани проблемы. – СПб.: Эко-Вектор, 2017. – 615 с. [Yarmolinskaya MI, Aylamazyan EK. Genital’nyy endometrioz. Razlichnyye grani problemy. Saint Petersburg: Eko-Vektor; 2017. 615 р. (In Russ.)]
  19. Адамян Л.В., Кулаков В.И. Эндометриозы: руководство для врачей. – М.: Медицина, 1998. – 317 с. [Adamyan LV, Kulakov VI. Endometriozy: rukovodstvo dlya vrachey. Moscow: Meditsina; 1998. 317 р. (In Russ.)]
  20. Эндометриоз. Клинические рекомендации. – М.: Российское общество акушеров-гинекологов, 2016. – 52 с. [Endometrioz. Klinicheskiye rekomendatsii. Moscow: Rossiyskoye obshchestvo akusherov-ginekologov; 2016. 52 р. (In Russ.)]. Доступно по: https://medi.ru/klinicheskie-rekomendatsii/endometrioz_13935/. Ссылка активна на 14.12.2019.
  21. Барто Р.А., Чечнева М.А., Попов А.А., Камалова А.Н. Ультразвуковая диагностика в стадировании наружного генитального эндометриоза // Российский электронный журнал лучевой диагностики. − 2019. − Т. 9. − № 1. − С. 131−141. [Barto RA, Chechneva MA, Popov AA, Kamalova AN. Diagnostic ultrasound in the staging of external genital endometriosis. Rossiiskii elektronnyi zhurnal luchevoi diagnostiki. 2019;9(1):131-141. (In Russ.)]. https://doi.org/10.21569/2222-7415-2019-9-1-131-141.
  22. Kinkel K, Ascher SM, Reinhold C. Benign disease of the uterus. In: Hodler J, Kubik-Huch RA, von Schulthess GK, ed. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging – IDKD Book [Internet]. Cham (CH): Springer; 2018. Chapter 3. Available from: http://www.ncbi.nlm.nih.gov/books/NBK543803/.
  23. Демидов В.Н. Экстрагенитальный эндометриоз и его ультразвуковая диагностика // Ультразвуковая и функциональная диагностика. – 2010. – № 3. – С. 102−111. [Demidov V.N. Extragenital Endometriosis Ultrasound Diagnostics. Ultrasound and functional diagnostics. 2010;(3):102-111. (In Russ.)]
  24. Hricak H, Alpers C, Crooks LE, Sheldon PE. Magnetic resonance imaging of the female pelvis: initial experience. AJR Am J Roentgenol. 1983;141(6):1119-1128. https://doi.org/10.2214/ajr.141.6.1119.
  25. Meylaerts LJ, Wijnen L, Grieten M, et al. Junctional zone thickness in young nulliparous women according to menstrual cycle and hormonal contraception use. Reprod Biomed Online. 2017;34(2):212-220. https://doi.org/10.1016/j.rbmo.2016.10.013.
  26. Shen X, Duan H, Wang S, et al. Expression of cannabinoid receptors in myometrium and its correlation with dysmenorrhea in adenomyosis. Reprod Sci. 2019;26(12):1618-1625. https://doi.org/10.1177/1933719119833483.
  27. Exacoustos C, Luciano D, Corbett B, et al. The uterine junctional zone: a 3-dimensional ultrasound study of patients with endometriosis. Am J Obstet Gynecol. 2013;209(3):248.e1-7. https://doi.org/10.1016/j.ajog.2013.06.006.
  28. Zhang Y, Yu P, Sun FJ, et al. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 2015;94(4):412-418. https://doi.org/10.1111/aogs.12595.
  29. Scoutt LM, Flynn SD, Luthringer DJ, et al. Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens. Radiology. 1991;179(2):403-407. https://doi.org/10.1148/radiology.179.2.2014282.
  30. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update. 2012;18(4):374-392. https://doi.org/10.1093/humupd/dms006.
  31. Richter ON, Bartz C, Dowaji J, et al. Contractile reactivity of human myometrium in isolated non-pregnant uteri. Hum Reprod. 2006;21(1):36-45. https://doi.org/10.1093/humrep/dei295.
  32. Tamai K, Togashi K, Ito T, et al. MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics. 2005;25(1):21-40. https://doi.org/10.1148/rg.251045060.
  33. Ярмолинская М.И. Генитальный эндометриоз: влияние гормональных, иммунологических и генетических факторов на развитие, особенности течения и выбор терапии: Дис. … д-ра мед. наук. – СПб., 2009. – 349 с. [Yarmolinskaya MI. Genital’nyy endometrioz: vliyaniye gormonal’nykh, immunologicheskikh i geneticheskikh faktorov na razvitiye, osobennosti techeniya i vybor terapii. [dissertation] Saint Petersburg; 2009. 349 р. (In Russ.)]. Доступно по: https://search.rsl.ru/ru/record/01004804625. Ссылка активна на 14.12.2019.
  34. Hernández Guerrero CA, Tlapanco Barba R, Ramos Pérez C, et al. Endometriosis and discouragement of immunology cytotoxic characteristics. Ginecol Obstet Mex. 2003;71:559-574.
  35. Szyllo K, Tchorzewski H, Banasik M, et al. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm. 2003;12(3):131-138. https://doi.org/10.1080/0962935031000134842.
  36. Özçelik K, Çapar M, Gazi Uçar M, et al. Are cytokine levels in serum, endometrial tissue, and peritoneal fluid a promising predictor to diagnosis of endometriosis-adenomyosis? Clin Exp Obstet Gynecol. 2016;43(4):569-572.
  37. Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Semin Diagn Pathol. 2010;27(4):226-240. https://doi.org/10.1053/j.semdp.2010.09.001.
  38. Jiang C, Gong W, Chen R, et al. RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis. J Int Med Res. 2018;46(12):5019-5029. https://doi.org/10.1177/0300060518789038.
  39. Tsai CL, Lee YS, Chao A, et al. Associations between a single nucleotide polymorphism of stress-induced phosphoprotein 1 and endometriosis/adenomyosis. Taiwan J Obstet Gynecol. 2018;57(2):270-275. https://doi.org/10.1016/ j.tjog.2018.03.001.
  40. Govatati S, Kodati VL, Deenadayal M, et al. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study. Hum Reprod. 2014;29(2):324-336. https://doi.org/10.1093/humrep/det387.
  41. Zhang H, Liu J, Zhao X, et al. Loss of PP2A and PTEN immunoexpression coexists with survivin overexpression in adenomyosis. Reprod Biol. 2014;14(3):200-205. https://doi.org/10.1016/j.repbio.2014.04.004.
  42. Hu H, Li H, He Y. MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis. Exp Ther Med. 2017;14(4):3805-3811. https://doi.org/10.3892/etm.2017.5013.
  43. Yang JH, Wu MY, Chen CD, et al. Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod. 2007;22(4):945-952. https://doi.org/10.1093/humrep/del493.
  44. Brosens JJ, de Souza NM, Barker FG. Uterine junctional zone: function and disease. Lancet. 1995;346(8974):558-560. https://doi.org/10.1016/S0140-6736(95)91387-4.
  45. De ZD, Bulletti C, Farichin R, et al. Contractility of the non-pregnant uterus: the follicular phase. Ann N Y Acad Sci. 2001;943:172-184. https://doi.org/10.1111/j.1749- 6632.2001.tb03801.x.
  46. Huang M, Li X, Guo P, et al. The abnormal expression of oxytocin receptors in the uterine junctional zone in women with endometriosis. Reprod Biol Endocrinol. 2017;15(1):1. https://doi.org/10.1186/s12958-016-0220-7.
  47. Bulletti C, de Ziegler D, Polli V, et al. Uterine contractility during the menstrual cycle. Hum Reprod. 2000;15(Suppl 1): 81-89. https://doi.org/10.1093/humrep/15.suppl_1.81.
  48. Gupta D, Hull ML, Fraser I, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4:CD012165. https://doi.org/10.1002/14651858.CD012165.
  49. Kiesel L, Sourouni M. Diagnosis of endometriosis in the 21st century. Climacteric. 2019;22(3):296-302. https://doi.org/10.1080/13697137.2019.1578743.
  50. Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;(5):CD012179. https://doi.org/10.1002/14651858.CD012179.

Copyright (c) 2020 Shalina M.A., Yarmolinskaya M.I., Abashova E.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies